- World rank, 2022–2025
- #16,580 of 28,054 · #26,997 all time
- Rank in China
- #2,581 of 3,058
- Research works
- 130 ▲ 185% vs 2013–17
- Citations
- 1.8k 14.2 per fractional work
- Top-10% rate
- 19.1% record average 16.5%
- Open access
- 44% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.4×. Every wedge is a field page.
- Immunology and Microbiology 5.4×
- Biochemistry, Genetics and Molecular Biology 3.7×
- Chemistry 1.9×
- Materials Science 1.9×
- Chemical Engineering 1.7×
- Energy 1.5×
- Engineering 1.4×
- Medicine 1.3×
- Pharmacology, Toxicology and Pharmaceutics 1.1×
- Dentistry 1.1×
- Environmental Science 0.8×
- Neuroscience 0.6×
- Nursing 0.6×
- Decision Sciences 0.5×
- Computer Science 0.5×
- Agricultural and Biological Sciences 0.5×
- Economics, Econometrics and Finance 0.4×
- Health Professions 0.3×
- Business, Management and Accounting 0.2×
- Earth and Planetary Sciences 0.1×
- Psychology 0.1×
- Physics and Astronomy 0.1×
- Social Sciences 0.0×
Which keywords describe research at Lifetech Scientific (China)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Cancer Immunotherapy, Monoclonal Antibodies, Glycosylation, Breast Cancer, Lab-on-a-Chip, Fc Receptors and Therapeutic Antibodies.
- Trastuzumab
- HER2
- Microfluidic Devices
- Chemotherapy
- Percutaneous Coronary Intervention
- Drug Delivery
- Atherosclerosis
- Monoclonal Antibody
- Dendritic Cells
- Biosensors
- Innate Immunity
- Tumor Regression
- Nanoparticles
- Fc Receptors
- Antigen Presentation
- Breast Cancer
- Inflammation
- Cancer
- Cancer Immunotherapy
- Machine Learning
- Immunotherapy
- Biomedical Applications
- Monoclonal Antibodies
- Glycosylation
- Tissue Engineering
- Lab-on-a-Chip
- Cancer Therapy
- Immunity
- Therapeutic Antibodies
- Gene Therapy
- Nanocomposites
- Tumor Targeting
- Gene Expression
- Tumor Antigen
- Biomarkers
- Drug Discovery
- Point-of-Care Diagnostics
- Lymphoma
- Pharmacology
- Regenerative Medicine
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Immunotherapy3▲ 6.4×6 topics
- Machine Learning2◆ 1.11×10 topics
- Biomedical Applications2▲ 2.9×13 topics
- Cancer Immunotherapy2▲ 23×2 topics
- Monoclonal Antibodies2▲ 36×2 topics
- Cancer2▲ 2.3×12 topics
- Glycosylation2▲ 27×2 topics
- Inflammation2▲ 1.45×21 topics
- Tissue Engineering2▲ 4.6×8 topics
- Breast Cancer2▲ 12×3 topics
- Lab-on-a-Chip2▲ 22×4 topics
- Antigen Presentation2▲ 28×2 topics
- Cancer Therapy2▲ 4.5×7 topics
- Fc Receptors2▲ 47×1 topic
- Immunity2▲ 6.1×3 topics
- Nanoparticles2▲ 2.0×8 topics
- Therapeutic Antibodies2▲ 37×1 topic
- Tumor Regression2▲ 23×2 topics
- Gene Therapy2▲ 13×4 topics
- Innate Immunity2▲ 7.4×2 topics
- Nanocomposites2▲ 3.0×8 topics
- Biosensors1▲ 4.3×5 topics
- Tumor Targeting1▲ 12×3 topics
- Dendritic Cells1▲ 23×1 topic
- Gene Expression1▲ 3.4×6 topics
- Monoclonal Antibody1▲ 39×2 topics
- Tumor Antigen1▲ 33×1 topic
- Atherosclerosis1▲ 6.7×3 topics
- Biomarkers1▲ 2.7×6 topics
- Drug Delivery1▲ 3.6×6 topics
- Drug Discovery1▲ 8.6×4 topics
- Percutaneous Coronary Intervention1▲ 14×2 topics
- Point-of-Care Diagnostics1▲ 23×2 topics
- Chemotherapy1▲ 2.4×2 topics
- Lymphoma1▲ 11×3 topics
- Microfluidic Devices1▲ 15×2 topics
- Pharmacology1▲ 6.7×6 topics
- HER21▲ 55×1 topic
- Regenerative Medicine1▲ 6.4×3 topics
- Trastuzumab1▲ 35×1 topic
Which research topics does Lifetech Scientific (China) publish most on?
By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, Immunotherapy and Immune Responses, HER2/EGFR in Cancer Research and CAR-T cell therapy research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
- 2 Immunotherapy and Immune Responses Immunology 1 works
- 3 HER2/EGFR in Cancer Research Oncology 1 works
- 4 CAR-T cell therapy research Oncology 1 works
- 5 Coronary Interventions and Diagnostics Surgery 1 works
- 6 Fault Detection and Control Systems Control and Systems Engineering 1 works
- 7 Biosensors and Analytical Detection Biomedical Engineering 1 works
- 8 Immune Cell Function and Interaction Immunology 1 works
- 9 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
- 10 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Lifetech Scientific (China)'s research output changed?
Output in 2018–2022 was 185% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Shenzhen
- Shenzhen University
- Southern University of Science and Technology
- Shenzhen Institutes of Advanced Technology
- Chinese University of Hong Kong, Shenzhen
- Huawei Technologies (China)
- Shenzhen Polytechnic University
- Peng Cheng Laboratory
- University Town of Shenzhen
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.